Pharmacokinetics of a new anti-HIV agent VP-0501 and development of its amino acid prodrug for improving oral bioavailability |
Cho, Hee-Jeong
(College of Veterinary Medicine, Konkuk University)
Choi, Kyung-Ae (College of Veterinary Medicine, Konkuk University) Sung, Ji-Min (College of Veterinary Medicine, Konkuk University) Jeong, Sang-Min (College of Veterinary Medicine, Konkuk University) Han, Jin-Soo (College of Veterinary Medicine, Konkuk University) Kim, Jin-Suk (College of Veterinary Medicine, Konkuk University) Shin, Ho-Chul (College of Veterinary Medicine, Konkuk University) |
1 | Arnold E, Das K, Ding J, Yadav PN, Hsiou Y, Boyer PL, Hughes SH. Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. Drug Des Discov 1996, 13, 29-47 |
2 | Bras AP, Sitar DS, Aoki FY. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol 2001, 8, 207-211 |
3 | Song X, Vig BS, Lorenzi PL, Drach JC, Townsend LB, Amidon GL. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(-D-ribofuranosyl) benzimidazole as potential substrates of hPEPT1 transporter. J Med Chem 2005, 48, 1274-1277 DOI ScienceOn |
4 | Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995, 28, 281-290 DOI ScienceOn |
5 | Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin AT. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004, 93, 1165-1175 DOI ScienceOn |
6 | Haase AT. Viral gene expression and pathogenesis in three emerging diseases: HIV and AIDS; HTLV-I and HAM/TSP; and HHV-8 and Kaposi's sarcoma. FEMS Immunol Med Microbiol 1997, 18, 301-305 DOI |
7 | Sridevi S, Chauhan AS, Chalasani KB, Jain AK, Diwan PV. Enhancement of dissolution and oral, bioavailability of gliquidone with hydroxy propyl-betacyclodextrin. Pharmazie 2003, 58, 807-810 |
8 | Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PA, Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the threedimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol 1994, 243, 369-387 DOI ScienceOn |
9 | Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carroll SS, et. al. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 1995, 39, 2602-2605 DOI ScienceOn |
10 | De Clercq E, Field HJ. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br J Pharmacol 2006, 147, 1-11 DOI ScienceOn |
11 | Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull 2004, 27, 1993-1999 DOI ScienceOn |
12 | Vig BS, Lorenzi PJ, Mittal S, Landowski CP, Shin HC, Mosberg HI, Hilfinger JM, Amidon GL. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis. Pharm Res 2003, 20, 1381-1388 DOI ScienceOn |
13 | Bardsley-Elliot A, Perry CM. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection. Paediatr Drugs 2000, 2, 373-407 DOI ScienceOn |
14 | Lorenzi PL, Landowski CP, Song X, Borysko KZ, Breitenbach JM, Kim JS, Hilfinger JM, Townsend LB, Drach JC, Amidon GL. Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1--D-ribofuranosyl) benzimidazole Enhance Metabolic Stability in Vitro and in Vivo. J Pharmacol Exp Ther 2005, 314, 883-890 DOI ScienceOn |
15 | Kondo N, Iwao T, Hirai K, Fukuda M, Yamanouchi K, Yokoyama K, Miyaji M, Ishihara Y, Kon K, Ogawa Y, et. al. Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J Pharm Sci 1994, 83, 566-570 DOI ScienceOn |
16 | Lin JH, Storey DE, Chen IW, Xu X. Improved oral absorption of L-365,260, a poorly soluble drug. Biopharm Drug Dispos 1996, 17, 1-15 DOI ScienceOn |
17 | Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacother 1997, 31, 185-191 DOI |
18 | Sriram D, Yogeeswari P, Srichakravarthy N, Bal TR. Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Bioorg Med Chem Lett 2004, 14, 1085-1087 DOI ScienceOn |
19 | Tashiro K, Ikegawa M, Yabe D, Honjo T. [Anti-HIV-1 genes; genetic restriction of AIDS pathogenesis by gene variants]. Nippon Rinsho 1999, 57, 967-974 |